Stock screenerAll disclosures →
EDGAR →
DNLI
Conviction 87HealthcareScan · Mon, Aug 10, 2026DNLI$25.00+0.68%
ResistanceSupportVol 14Vol MA14 1.57M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price25.00
Change+0.68%
Gap-0.77%
Rel volume1.35×
Avg volume1.8M
Avg $ vol42.53M
SMA 2023.69
SMA 5023.48
SMA 20020.07
Price vs 50+6.48%
Price vs 200+24.54%
MA stackbullish
50/200 cross—
Supertrenddown · 26.43
RSI (14)58
MACD hist0.10
MACD crossbull · 2d
Stoch %K / %D76 / 79
ADX (14)18
+DI / −DI25 / 17
RSI divergence—
MACD divergenceBullish
ATR %+4.33%
ADR %4.77%
52w high27.21
52w low12.75
From 52w high-8.12%
Above 52w low+96.08%
New 52w highNo
SqueezeOff
Bollinger width11.87%
%B0.97
Donchian pos69.37%
Donchian high26.32
Donchian low22.01
AVWAP (52w high)24.03
vs AVWAP high+4.02%
AVWAP (52w low)19.70
vs AVWAP low+26.93%
OBV trendFlat
Chaikin MF (20)0.07
Today vs 20d1.35×
Avg vol (14d)1.57M
Avg vol (20d)1.8M
Avg $ vol (20d)42.53M
Market cap4B
RS 3m (vs SPY)+20.28%
RS 6m (vs SPY)+9.91%
RS line new highNo
Trend template8/8
Technical rank72.5
1 week+7.99%
1 month-2.65%
3 months+27.42%
6 months+18.60%
1 year+75.69%
YTD+53.66%
P/E-7.80
P/B4.78
P/S—
P/FCF-9.47
EPS-2.97
Div yield—
ROE-61.37%
ROA-44.26%
Debt/Eq—
Current8.37
EV/EBITDA-6.97
Gross margin—
Net margin—
Rev growth—
EPS growth-21.23%
Price target36.31
Target upside45.24%
Analyst ratingBuy
Institutional105.33%
Ent. value3.79B
Revenue3.6M
Net income-127.55M
Gross profit—
Free cash flow-422.1M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out158.71M
Employees507
ListedFri, Dec 8, 2017
Free float128.21M
Float %87.4%
Short interest16.04M
Days to cover8.4d
Short volume68.8%
Squeeze score75 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.68 vs −$0.72
Last surprise+5.6% beat
Setup gradeA
Conviction87 / 100
Pattern quality—
Tech rank72.5 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance27.05
Support22.27
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in DNLI
No recent disclosed trades by Congress in DNLI. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in DNLI · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Baker Brothers Life Sciences LP Director · Common Stock · 2026-06-03 | Grant | 6.41K | $0 | 2026-06-03 | 2026-06-05 |
BAKER JULIAN Director · Common Stock · 2026-06-03 | Grant | 6.41K | $0 | 2026-06-03 | 2026-06-05 |
BAKER FELIX Director · Common Stock · 2026-06-03 | Grant | 6.41K | $0 | 2026-06-03 | 2026-06-05 |
BAKER JULIAN Director · Non- Qualified Stock Option (right to buy) · 2026-06-03 | Grant | 19.23K | $0 | 2026-06-03 | 2026-06-05 |
Baker Bros. Advisors (GP) LLC Director · Non- Qualified Stock Option (right to buy) · 2026-06-03 | Grant | 19.23K | $0 | 2026-06-03 | 2026-06-05 |
BAKER BROS. ADVISORS LP Director · Non- Qualified Stock Option (right to buy) · 2026-06-03 | Grant | 19.23K | $0 | 2026-06-03 | 2026-06-05 |
BAKER BROS. ADVISORS LP Director · Non-Qualified Stock Option (right to buy) · 2026-06-03 | Grant | 19.23K | $0 | 2026-06-03 | 2026-06-05 |
Baker Brothers Life Sciences LP Director · Non- Qualified Stock Option (right to buy) · 2026-06-03 | Grant | 19.23K | $0 | 2026-06-03 | 2026-06-05 |
Schenkein David P Director · Common Stock · 2026-06-03 | Grant | 6.41K | $0 | 2026-06-03 | 2026-06-05 |
Cook Jennifer E. Director · Stock Option (right to buy) · 2026-06-03 | Grant | 19.23K | $0 | 2026-06-03 | 2026-06-05 |
SEC filings
EDGAR filings in DNLI · 7 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.